» Authors » Joanna C Moullin

Joanna C Moullin

Explore the profile of Joanna C Moullin including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 44
Citations 1161
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Toll K, Robinson S, Andrew S, Williams A, Yeung J, Varhol R, et al.
BMC Health Serv Res . 2025 Jan; 25(1):189. PMID: 39891131
Background: Rural provider-to-provider telehealth is growing globally. It is used to both facilitate equitable access to specialist healthcare services for those living in rural and remote areas and provide support...
2.
Pang B, McVeigh J, Thompson C, Thogersen-Ntoumani C, Stamatakis E, Moullin J
Health Promot J Austr . 2025 Jan; 36(1):e957. PMID: 39776160
Issue Addressed: Australian adults transitioning into retirement aged 55-75 years (> 50%) do not meet the World Health Organization recommendation of physical activity (PA). One potential strategy to promote PA...
3.
Aarons G, Sklar M, Ehrhart M, Roesch S, Moullin J, Carandang K
J Subst Use Addict Treat . 2024 Jun; 165:209437. PMID: 38866139
Introduction: Evidence-based practice (EBP) implementation represents a strategic change that requires alignment of leadership and support throughout organizations. Leadership and Organizational Change for Implementation (LOCI) is a multifaceted implementation strategy...
4.
Toll K, Moullin J, Andrew S, Williams A, Varhol R, Carey T, et al.
Digit Health . 2024 Apr; 10:20552076241242790. PMID: 38571877
Background: Virtual healthcare solutions are proposed as a way to combat the inequity of access to healthcare in rural and remote areas, and to better support the front-line providers who...
5.
Moullin J, Staniland L, Uren H, Nielsen S, Lenton S
Drug Alcohol Rev . 2024 Jan; 43(3):746-759. PMID: 38287683
Introduction: Opioid-related overdose fatalities are rising despite the increased accessibility of take-home naloxone (THN). Targeted implementation strategies are needed to improve the distribution of naloxone. This study investigates the effectiveness...
6.
Pang B, Moullin J, Thompson C, Thogersen-Ntoumani C, Stamatakis E, McVeigh J
J Aging Phys Act . 2024 Jan; 32(3):446-459. PMID: 38237573
Despite the well-known benefits of physical activity, less than half of adults aged 55-75 years participate in sufficient physical activity. Short bouts of vigorous intermittent lifestyle physical activity (VILPA) accumulated...
7.
Langford A, Bero L, Lin C, Blyth F, Doctor J, Holliday S, et al.
J Clin Epidemiol . 2023 Nov; 165:111204. PMID: 37931823
Objectives: To describe the development and use of an Evidence to Decision (EtD) framework when formulating recommendations for the Evidence-Based Clinical Practice Guideline for Deprescribing Opioid Analgesics. Study Design And...
8.
McDonald M, Brickley B, Pavey T, Smith J, Maiorana A, McCaffrey T, et al.
BMJ Open . 2023 Oct; 13(10):e078302. PMID: 37879681
Introduction: Improving physical activity (PA) and healthy eating is critical for primary and secondary prevention of cardiovascular disease (CVD). Behaviour change programmes delivered in sporting clubs can engage men in...
9.
Sarkies M, Testa L, Best S, Moullin J, Sullivan D, Bishop W, et al.
Heart Lung Circ . 2023 Oct; 32(11):1347-1353. PMID: 37865587
Background: Familial hypercholesterolaemia (FH) is a genetic condition that is a preventable cause of premature cardiovascular morbidity and mortality. High-level evidence and clinical practice guidelines support preventative care for people...
10.
Mena S, Moullin J, Schneider M, Niquille A
BMC Geriatr . 2023 Oct; 23(1):620. PMID: 37789286
Background: Polypharmacy and potentially inappropriate medications (PIMs) are still frequent among older adults in nursing homes. Deprescribing is an intervention that has been shown to be effective in reducing their...